844 related articles for article (PubMed ID: 25542414)
1. Change in novel filtration markers and risk of ESRD.
Rebholz CM; Grams ME; Matsushita K; Selvin E; Coresh J
Am J Kidney Dis; 2015 Jul; 66(1):47-54. PubMed ID: 25542414
[TBL] [Abstract][Full Text] [Related]
2. Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes.
Foster MC; Inker LA; Hsu CY; Eckfeldt JH; Levey AS; Pavkov ME; Myers BD; Bennett PH; Kimmel PL; Vasan RS; Coresh J; Nelson RG;
Am J Kidney Dis; 2015 Jul; 66(1):75-83. PubMed ID: 25773485
[TBL] [Abstract][Full Text] [Related]
3. Risk of ESRD and Mortality Associated With Change in Filtration Markers.
Rebholz CM; Inker LA; Chen Y; Liang M; Foster MC; Eckfeldt JH; Kimmel PL; Vasan RS; Feldman HI; Sarnak MJ; Hsu CY; Levey AS; Coresh J;
Am J Kidney Dis; 2017 Oct; 70(4):551-560. PubMed ID: 28648303
[TBL] [Abstract][Full Text] [Related]
4. Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study.
Kim S; Hwang S; Jang HR; Sohn I; Ahn HS; Park HD; Huh W; Jin DC; Kim YG; Kim DJ; Oh HY; Lee JE
BMC Nephrol; 2019 Jun; 20(1):214. PubMed ID: 31185945
[TBL] [Abstract][Full Text] [Related]
5. Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study.
Foster MC; Coresh J; Hsu CY; Xie D; Levey AS; Nelson RG; Eckfeldt JH; Vasan RS; Kimmel PL; Schelling J; Simonson M; Sondheimer JH; Anderson AH; Akkina S; Feldman HI; Kusek JW; Ojo AO; Inker LA;
Am J Kidney Dis; 2016 Jul; 68(1):68-76. PubMed ID: 26948990
[TBL] [Abstract][Full Text] [Related]
6. Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis.
Inker LA; Coresh J; Sang Y; Hsu CY; Foster MC; Eckfeldt JH; Karger AB; Nelson RG; Liu X; Sarnak M; Appel LJ; Grams M; Xie D; Kimmel PL; Feldman H; Ramachandran V; Levey AS;
Clin J Am Soc Nephrol; 2017 Jan; 12(1):69-78. PubMed ID: 28062677
[TBL] [Abstract][Full Text] [Related]
7. Short-term change in kidney function and risk of end-stage renal disease.
Turin TC; Coresh J; Tonelli M; Stevens PE; de Jong PE; Farmer CK; Matsushita K; Hemmelgarn BR
Nephrol Dial Transplant; 2012 Oct; 27(10):3835-43. PubMed ID: 22764191
[TBL] [Abstract][Full Text] [Related]
8. Albuminuria and Estimated GFR as Risk Factors for Dementia in Midlife and Older Age: Findings From the ARIC Study.
Scheppach JB; Coresh J; Wu A; Gottesman RF; Mosley TH; Knopman DS; Grams ME; Sharrett AR; Koton S
Am J Kidney Dis; 2020 Dec; 76(6):775-783. PubMed ID: 32428540
[TBL] [Abstract][Full Text] [Related]
9. Kidney function and sudden cardiac death in the community: The Atherosclerosis Risk in Communities (ARIC) Study.
Suzuki T; Agarwal SK; Deo R; Sotoodehnia N; Grams ME; Selvin E; Calkins H; Rosamond W; Tomaselli G; Coresh J; Matsushita K
Am Heart J; 2016 Oct; 180():46-53. PubMed ID: 27659882
[TBL] [Abstract][Full Text] [Related]
10. Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.
Rebholz CM; Grams ME; Matsushita K; Inker LA; Foster MC; Levey AS; Selvin E; Coresh J
Clin J Am Soc Nephrol; 2015 Jun; 10(6):941-8. PubMed ID: 25825481
[TBL] [Abstract][Full Text] [Related]
11. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.
Astor BC; Shafi T; Hoogeveen RC; Matsushita K; Ballantyne CM; Inker LA; Coresh J
Am J Kidney Dis; 2012 May; 59(5):653-62. PubMed ID: 22305758
[TBL] [Abstract][Full Text] [Related]
12. Association of kidney function and albuminuria with prevalent and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) study.
Huang M; Matsushita K; Sang Y; Ballew SH; Astor BC; Coresh J
Am J Kidney Dis; 2015 Jan; 65(1):58-66. PubMed ID: 25151408
[TBL] [Abstract][Full Text] [Related]
13. Kidney Function and Fracture Risk: The Atherosclerosis Risk in Communities (ARIC) Study.
Daya N; Voskertchian A; Schneider ALC; Ballew S; McAdams DeMarco M; Coresh J; Appel LJ; Selvin E; Grams ME
Am J Kidney Dis; 2016 Feb; 67(2):218-226. PubMed ID: 26250781
[TBL] [Abstract][Full Text] [Related]
14. Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney.
Foster MC; Levey AS; Inker LA; Shafi T; Fan L; Gudnason V; Katz R; Mitchell GF; Okparavero A; Palsson R; Post WS; Shlipak MG
Am J Kidney Dis; 2017 Sep; 70(3):406-414. PubMed ID: 28549536
[TBL] [Abstract][Full Text] [Related]
15. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.
Chen DC; Shlipak MG; Scherzer R; Bauer SR; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
JAMA Netw Open; 2022 Feb; 5(2):e2148940. PubMed ID: 35175342
[TBL] [Abstract][Full Text] [Related]
16. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
Yoshizawa T; Okada K; Furuichi S; Ishiguro T; Yoshizawa A; Akahoshi T; Gon Y; Akashiba T; Hosokawa Y; Hashimoto S
Int J Chron Obstruct Pulmon Dis; 2015; 10():1283-9. PubMed ID: 26185434
[TBL] [Abstract][Full Text] [Related]
18. Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study.
Kanda E; Usui T; Kashihara N; Iseki C; Iseki K; Nangaku M
Clin Exp Nephrol; 2018 Apr; 22(2):318-327. PubMed ID: 28884361
[TBL] [Abstract][Full Text] [Related]
19. Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure.
Chen DC; Shlipak MG; Scherzer R; Bansal N; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
Am J Kidney Dis; 2022 Dec; 80(6):762-772.e1. PubMed ID: 35817274
[TBL] [Abstract][Full Text] [Related]
20. Cystatin C-based eGFR is a superior prognostic parameter to creatinine-based eGFR in post-endovascular therapy peripheral artery disease patients.
Otaki Y; Takahashi H; Watanabe T; Yamaura G; Funayama A; Arimoto T; Shishido T; Miyamoto T; Kubota I
Circ J; 2015; 79(11):2480-6. PubMed ID: 26354502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
